Entero Healthcare Solutions Limited (ENTERO.NS)
- Previous Close
1,286.60 - Open
1,285.60 - Bid --
- Ask --
- Day's Range
1,190.00 - 1,287.00 - 52 Week Range
991.10 - 1,584.25 - Volume
259,237 - Avg. Volume
67,553 - Market Cap (intraday)
53.137B - Beta (5Y Monthly) --
- PE Ratio (TTM)
56.20 - EPS (TTM)
21.73 - Earnings Date Aug 13, 2025 - Aug 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1,495.00
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, healthcare product manufacturers, and healthcare clinics in India. The company is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. It also offers nebulizers, digital thermometers, blood pressure monitors, and adult diapers. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.
www.enterohealthcare.comRecent News: ENTERO.NS
View morePerformance Overview: ENTERO.NS
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare to: ENTERO.NS
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: ENTERO.NS
View moreValuation Measures
Market Cap
52.24B
Enterprise Value
51.08B
Trailing P/E
55.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.03
Price/Book (mrq)
3.03
Enterprise Value/Revenue
1.00
Enterprise Value/EBITDA
24.20
Financial Highlights
Profitability and Income Statement
Profit Margin
1.86%
Return on Assets (ttm)
3.49%
Return on Equity (ttm)
6.30%
Revenue (ttm)
50.96B
Net Income Avi to Common (ttm)
948.2M
Diluted EPS (ttm)
21.73
Balance Sheet and Cash Flow
Total Cash (mrq)
3.18B
Total Debt/Equity (mrq)
21.76%
Levered Free Cash Flow (ttm)
-3.94B